Mr. Bilirakis (for himself, Ms. Barragán, Mrs. Cammack, Mr. Auchincloss, Mr. Kean, and Mr. Mullin) introduced the following bill; which was referred to the Committee on Energy and Commerce
To amend the Federal Food, Drug, and Cosmetic Act to permanently extend the authority of the Secretary of Health and Human Services to award priority review vouchers for rare pediatric disease products.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Priority for Pediatric Cures Act. H.R. 10359. 119th
Cong., 2nd
sess., Introduced in House September 14, 2026. https://www.govinfo.gov/app/details/BILLS-119hr10359ih.
APA
Congress, House of Representatives (2026, September 14). Priority for Pediatric Cures Act (H.R. 10359 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr10359ih.
MLA
United States, Congress, House of Representatives. Priority for Pediatric Cures Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr10359ih. 119th Congress, H.R. 10359, Introduced in House 14 Sep. 2026.
Bluebook
H.R.10359 - 119th Congress (2025-2026): Priority for Pediatric Cures Act, H.R.10359, 119th Cong. (2026), https://www.govinfo.gov/app/details/BILLS-119hr10359ih.
